Skip to main content
    E

    Ensysce Biosciences Inc (ENSC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.42
    +0.03 (+8.06%)

    Market Cap: $8.14M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Ensysce Biosciences Inc (ENSC) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Ensysce Biosciences (ENSC) to earn -$0.23 per share in the fiscal year ending Dec 31, 2026, on revenue of $4.67M. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.05.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates fall 21.4%.

    Fiscal year ending Dec 31, 2026
    -$0.23
    EPS consensus, revenue $4.67M
    Fiscal year ending Dec 31, 2027
    -$0.05
    EPS consensus, revenue $3.67M
    Next report
    Mar 29, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.23-$0.23 to -$0.231$4.67M$4.40M to $5.02M3
    Dec 31, 2027-$0.05-$0.06 to -$0.052$3.67M$3.00M to $4.34M2

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.08-$0.14 to -$0.014$900997N/A5

    Estimate Revisions

    No EPS estimate for the 2 periods below was revised in the last 30 days.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202600
    Fiscal year ending Dec 31, 202700

    EPS Trend

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2027-$0.05-$0.05-$0.05-$0.05-$0.05N/A

    Frequently Asked Questions About ENSC

    What is the ENSC stock forecast?

    Consensus analyst estimates put Ensysce Biosciences's EPS at -$0.23 for the fiscal year ending Dec 31, 2026, on revenue of $4.67M.

    What EPS do analysts expect from ENSC next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.23, with estimates from -$0.23 to -$0.23 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.05, with estimates from -$0.06 to -$0.05 from 2 analysts.

    What revenue do analysts expect from Ensysce Biosciences next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $4.67M, with estimates from $4.40M to $5.02M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.67M, with estimates from $3.00M to $4.34M.

    How many analysts cover ENSC?

    1 analyst estimates EPS for Ensysce Biosciences for the fiscal year ending Dec 31, 2026.